Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

Authors: Emily E. Coates, Srilatha Edupuganti, Grace Chen, Myra Happe, Larisa Strom, Alicia T. Widge, Maria Burgos Florez, Josephine H. Cox, Ingelise J. Gordon, Sarah H. Plummer, Abidemi Ola, Galina V. Yamshchikov, Charla Andrews, Sharon Curate-Ingram, Patricia Morgan, Shashi Nagar, Matthew H. Collins, Amy Bray, Thuy Nguyen, Judy Stein, Christopher L. Case, Florence Kaltovich, Diane Wycuff, Chen Liang, Kevin Carlton, Sandra Vazquez, John R. Mascola, Julie E. Ledgerwood, Ellie Butler, Jean M. Winter, Jianguo Xu, Amy Sherman, Colleen F. Kelley, Rameses Fredrick, Nadine Rouphael, Varun K. Phadke, Cynthia G. Whitney, Alicarmen Alvarez, Renata Dennis, Rebecca Fineman, Pamela Lankford-Turner, Sha Yi, Lilin Lai, Gena Burch, Shanker Gupta, Nina M. Berkowitz, Cristina Carter, Allison Beck, Brenda Larkin, Stephanie Taylor, Mandy Alger, Jessica Bahorich, Amy L. Chamberlain, Ya-Chen Chang, Rajoshi Chaudhuri, Jonathan W. Cooper, Jacob Demirji, Fan Yang, Alissa Fernald, Deepika Gollapudi, Janel Holland-Linn, Lisa A. Kueltzo, James Lee, Jie Liu, Xun Liu, Rachel Mowery, Sarah O’Connell, Erwin Rosales‐Zavala, J. S. Sands, Xin Wang, Shaojie Weng, Sara Witter - The Lancet 2022 cited by 38